Literature DB >> 230207

Lymphocyte function and virus infections.

A M Denman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230207      PMCID: PMC1521590          DOI: 10.1136/jcp.s3-13.1.39

Source DB:  PubMed          Journal:  J Clin Pathol Suppl (R Coll Pathol)        ISSN: 0144-0330


× No keyword cloud information.
  30 in total

1.  Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.

Authors:  K O Fresen; M S Cho; H zur Hausen
Journal:  Int J Cancer       Date:  1978-10-15       Impact factor: 7.396

2.  Herpes simplex virus type-1 and human lymphocytes: virus expression and the response to infection of adult and foetal cells.

Authors:  D Westmoreland
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

3.  Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes.

Authors:  M Steinitz; T Bakács; G Klein
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

4.  A new manifestation of infection with Epstein-Barr virus.

Authors:  H Smith; A M Denman
Journal:  Br Med J       Date:  1978-07-22

5.  Replication of herpes simplex virus in human B lymphocytes stimulated by Epstein-Barr virus.

Authors:  H Kirchner; C H Schröder
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

6.  Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.

Authors:  A J McMichael; B A Askonas
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

7.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

8.  Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion.

Authors:  J L Virelizier; G Lenoir; C Griscelli
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

9.  Possible initiation of viral encephalomyelitis in dogs by migrating lymphocytes infected with distemper virus.

Authors:  B A Summers; H A Greisen; M J Appel
Journal:  Lancet       Date:  1978-07-22       Impact factor: 79.321

10.  Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines.

Authors:  G Ju; S Udem; B Rager-Zisman; B R Bloom
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  5 in total

1.  Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.

Authors:  M I Joffe; N R Sukha; A R Rabson
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

2.  The positive expression of genotype VII Newcastle disease virus (Malaysian isolate) in Japanese quails (Coturnix coturnix japonica).

Authors:  Lizma Felisha Mazlan; Noor Farhana Bachek; Siti Nor Azizah Mahamud; Lokman Hakim Idris; Tan Sheau Wei; Abdul Rahman Omar; Mohd Hezmee Mohd Noor
Journal:  Vet World       Date:  2017-05-25

3.  Value of peripheral blood count for dengue severity prediction.

Authors:  Udaya Ralapanawa; A T M Alawattegama; Malinga Gunrathne; Sampath Tennakoon; S A M Kularatne; Thilak Jayalath
Journal:  BMC Res Notes       Date:  2018-06-20

Review 4.  Feline Morbillivirus, a New Paramyxovirus Possibly Associated with Feline Kidney Disease.

Authors:  Eun Jin Choi; Victoria Ortega; Hector C Aguilar
Journal:  Viruses       Date:  2020-05-01       Impact factor: 5.048

5.  Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.

Authors:  Jaskaran Khinda; Naveed Z Janjua; Shannon Cheng; Edwin R van den Heuvel; Parveen Bhatti; Maryam Darvishian
Journal:  J Med Virol       Date:  2020-09-28       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.